YD BioYDES
13F holders, Q3 2025 (September 30)10holders
$19.47avg. 13F price*
At the end of Q3 2025, 10 institutions reported holding YD Bio Ltd. (YDES) in their 13F filings. The largest holders were Geode Capital Management, LLC ($1.0M), Cerity Partners LLC ($631K) and HRT Financial LP ($619K).
- Company
- YD Bio Ltd.
- CUSIP
- G98301107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $3.3M |
| Exits | 0 | $0 |
Ownership 10 holders
| Geode Capital Management, LLC | 0.00% | New | 53,071 | $1.0M |
| Cerity Partners LLC | 0.00% | New | 32,406 | $631K |
| HRT Financial LP | 0.00% | New | 31,819 | $619K |
| Cypress Capital Management LLC (WY) | 0.59% | New | 29,990 | $584K |
| UBS Group AG | 0.00% | New | 10,316 | $201K |
| Morgan Stanley | 0.00% | New | 10,257 | $200K |
| Clear Street Group Inc. | 0.00% | — | 7,500 | $146K |
| BNP Paribas Financial Markets | 0.00% | New | 90 | $2K |
| Barclays PLC | 0.00% | New | 58 | $1K |
| FMR LLC | 0.00% | New | 1 | $19 |
"% of holder's portfolio" is YDES's weight in each manager's 13F, not the share of YD Bio Ltd. the manager owns.